New patent for Neurocrine drug INGREZZA

Annual Drug Patent Expirations for INGREZZA Ingrezza is a drug marketed by Neurocrine and is included in one NDA. It is available from one supplier. There are three patents protecting…
The post New patent for Neurocrine drug INGREZZA appeared first on …


Biotechblog